Related Experiment Video
Updated: Aug 19, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
Antioxidant nutrient supplementation and brachial reactivity in patients with coronary artery disease
Ronald McKechnie1, Melvyn Rubenfire, Lori Mosca
1Department of Internal Medicine, Division of Cardiology, University of Michigan Medical Center, Ann Arbor, MI, USA.
Insights
Combined antioxidant supplements did not improve endothelial function in patients with coronary artery disease (CAD), despite increasing plasma antioxidant levels. Further research is needed to evaluate individual antioxidant effects on cardiovascular health.
Area of Science:
- Cardiovascular Research
- Nutritional Science
- Clinical Trials
Background:
- Epidemiologic studies suggest a link between antioxidant intake and coronary artery disease (CAD).
- Clinical trial results on antioxidant supplementation for CAD have been inconsistent.
- The impact of combined antioxidants on endothelial function and LDL oxidation in CAD patients requires further investigation.
Purpose of the Study:
- To evaluate the effect of combined antioxidant supplementation on endothelial function in patients with established CAD.
- To assess the correlation between changes in endothelial function and low-density lipoprotein cholesterol (LDLC) oxidation.
- To compare the efficacy of two different dosages of combined antioxidant supplementation against a placebo.
Main Methods:
- A 12-week, double-blind, placebo-controlled trial involving 18 patients with established CAD.
- Randomization to placebo or two different doses of combined antioxidant supplements (vitamins E, C, and beta-carotene).
- Assessment of endothelial function via brachial artery diameter changes during reactive hyperemia; LDL oxidation measured by lag phase.
Main Results:
- Significant increases in plasma alpha-tocopherol, vitamin C, and beta-carotene were observed in the antioxidant groups compared to placebo.
- Both groups showed improved LDL oxidation lag phase, with a trend towards greater improvement in the treatment group (P=.06).
- No statistically significant improvement in brachial artery reactivity was found in the treatment group; the placebo group showed significant improvement (P<.05).
Conclusions:
- Combined antioxidant supplementation did not significantly improve endothelial function in patients with CAD.
- Despite increased plasma antioxidant levels and improved LDL oxidation lag phase, brachial reactivity was not significantly altered.
- Larger trials evaluating individual dietary antioxidants are recommended to clarify their role in cardiovascular health.
Abstract:
Epidemiologic studies have shown a correlation between antioxidant intake and coronary artery disease (CAD); however, the results of clinical trials have been inconsistent. We evaluated the effect of combined antioxidant supplementation on endothelial function and its correlation with change in low-density lipoprotein cholesterol (LDLC) oxidation in patients with established CAD. In a double-blind, placebo-controlled 12-week trial, 18 nonsmoking, nondiabetic patients (mean age 62.4 +/- 8.1 years) were randomized to receive placebo or antioxidant supplementation consisting of (a) 400 IU of vitamin E, 500 mg of vitamin C, and 12 mg of beta-carotene; or (b) 800 IU of vitamin E, 1000 mg of vitamin C, and 24 mg of beta-carotene daily. Endothelial function was evaluated on the basis of percent and absolute changes in brachial artery diameter in response to reactive hyperemia induced by occlusion-release. Baseline and 12-week values of LDL oxidation (measured on the basis of lag phase), endothelial function, dietary composition, serum antioxidants, and lipids were measured. We noted a significant between-group difference at 12 weeks for change in plasma concentrations of alpha-tocopherol, vitamin C, and beta-carotene between the placebo and antioxidant groups (p <.05). Both placebo and treatment groups demonstrated a significant improvement in lag phase; however, the treatment group achieved a greater, although nonsignificant, magnitude of change compared with the placebo group (181.3 +/- 177.8 minutes vs 80.6 +/- 63.0 minutes, P =.06). Within-group change in brachial reactivity from baseline to follow-up in the treatment group did not reach statistical significance (1.7% +/- 3.2% and 0.07 mm +/- 0.13 mm, P =.08 and P =.09, respectively), whereas an improved change in brachial reactivity was observed in the placebo group (2.2% +/- 1.9%, 0.09 mm +/- 0.06 mm, P <.05). No significant correlation was found between change in lag phase and change in endothelial function. On adjustment for confounders, antioxidant supplementation was found not to be a significant predictor of brachial reactivity. We conclude that antioxidant supplementation did not significantly alter brachial reactivity, despite significantly increased plasma levels of antioxidants and improved lag phase. These data should be confirmed in larger-scale trials and examined in studies evaluating individual dietary antioxidant supplementation.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management
Atherosclerosis III: Management

